OriGene Technologies, Inc., a leading biotechnology company headquartered in the United States, has been at the forefront of molecular biology since its founding in 1996. With a strong presence in North America, Europe, and Asia, OriGene focuses on providing innovative solutions in gene expression, protein production, and antibody development. The company is renowned for its extensive portfolio of high-quality products, including cDNA clones, antibodies, and gene expression assays, which are designed to accelerate research in genomics and proteomics. OriGene's commitment to quality and innovation has positioned it as a trusted partner for researchers and institutions worldwide. Notable achievements include the development of unique technologies that enhance the accuracy and efficiency of gene analysis, solidifying OriGene's reputation as a key player in the biotechnology industry.
How does OriGene Technologies, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
OriGene Technologies, Inc.'s score of 23 is lower than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
OriGene Technologies, Inc., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor does it report specific reduction targets or initiatives. As of now, there are no emissions figures, such as Scope 1, 2, or 3 emissions, nor any commitments to science-based targets (SBTi) or other climate pledges. In the absence of specific data, it is important to note that many companies in the biotechnology sector are increasingly focusing on sustainability and reducing their carbon footprints. However, without concrete information from OriGene Technologies, Inc., it is not possible to provide a detailed overview of their climate commitments or performance.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
OriGene Technologies, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

